| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |